Related references
Note: Only part of the references are listed.Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations
Chang Liu et al.
JAMA CARDIOLOGY (2022)
HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies
Guo-Chao Zhong et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals
Joris Deelen et al.
NATURE COMMUNICATIONS (2019)
High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction
Wynn G. Hunter et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia A Pooled Analysis of More Than 1 Million Participants
Jae Jeong Yang et al.
JAMA NETWORK OPEN (2019)
Night Shift Work, Genetic Risk, and Type 2 Diabetes in the UK Biobank
Celine Vetter et al.
DIABETES CARE (2018)
Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial
James D. Otvos et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke
Michael V. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Quantitative Lipoprotein Subclass and Low Molecular Weight Metabolite Analysis in Human Serum and Plasma by 1H NMR Spectroscopy in a Multilaboratory Trial
Beatriz Jimenez et al.
ANALYTICAL CHEMISTRY (2018)
HDL cholesterol concentration or HDL function: which matters?
Philip J. Barter et al.
EUROPEAN HEART JOURNAL (2017)
Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality inmen and women: two prospective cohort studies
Christian M. Madsen et al.
EUROPEAN HEART JOURNAL (2017)
Serum Concentration of HDL Particles Predicts Mortality in Acute Heart Failure Patients
Ines Potocnjak et al.
SCIENTIFIC REPORTS (2017)
High-Density Lipoprotein Subclasses, Coronary Artery Disease, and Cardiovascular Mortality
Guenther Silbernagel et al.
CLINICAL CHEMISTRY (2017)
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies
Peter Wurtz et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)
Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans
Carlos O. Mendivil et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Dysfunctional HDL and atherosclerotic cardiovascular disease
Robert S. Rosenson et al.
NATURE REVIEWS CARDIOLOGY (2016)
High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort
Robert W. McGarrah et al.
ATHEROSCLEROSIS (2016)
HDL Particle Size and Functional Heterogeneity
Sergio Fazio et al.
CIRCULATION RESEARCH (2016)
Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank
Sophie V. Eastwood et al.
PLOS ONE (2016)
HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export
Xian-Ming Du et al.
CIRCULATION RESEARCH (2015)
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics
Pasi Soininen et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
Cathie Sudlow et al.
PLOS MEDICINE (2015)
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics
Pasi Soininen et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative
Seth S. Martin et al.
EUROPEAN HEART JOURNAL (2015)
Low-density lipoprotein particle diameter and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
Tanja B. Grammer et al.
EUROPEAN HEART JOURNAL (2015)
Diabetic dyslipidemia
Liya Wu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Biomarker Profiling by Nuclear Magnetic Resonance Spectroscopy for the Prediction of All-Cause Mortality: An Observational Study of 17,345 Persons
Krista Fischer et al.
PLOS MEDICINE (2014)
Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies
Jun Liu et al.
LIPIDS IN HEALTH AND DISEASE (2013)
Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport
Robert S. Rosenson et al.
CIRCULATION (2012)
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2011)
Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy
Sajoscha A. Sorrentino et al.
CIRCULATION (2010)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Adaptive linear step-up procedures that control the false discovery rate
Yoav Benjamini et al.
BIOMETRIKA (2006)